---
title: "Omega Diagnostics Gp (ODX.L) AbC-19 rapid antibody test performance evaluation"
publisher: "Share Talk"
author: "sharetalk"
published: "2021-07-09T08:30:21+00:00"
modified: "2021-07-09T09:04:11+00:00"
date: 2021-07-09
canonical: "https://www.share-talk.com/omega-diagnostics-gp-odx-l-abc-19-rapid-antibody-test-performance-evaluation/"
category: "Healthcare"
categories: ["Healthcare"]
tags: ["Abingdon Health", "Administration", "Antigen Test", "china", "Colin King", "Contract", "COVID-19", "David Grouse", "diagnostic", "diseases", "Drug", "Food", "infectious", "Manufacturing", "Medical", "Mologic Ltd", "ODX", "Omega Diagnostics", "Omega Diagnostics Gp", "Rapid Test", "scientists", "Screen4", "UK Government", "UK-RTC", "University of Oxford"]
image: "https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1"
format: "news"
language: "en-GB"
---

# Omega Diagnostics Gp (ODX.L) AbC-19 rapid antibody test performance evaluation

**Published:** July 9, 2021
**Author:** sharetalk
**Categories:** Healthcare
**Tags:** Abingdon Health, Administration, Antigen Test, china, Colin King, Contract, COVID-19, David Grouse, diagnostic, diseases, Drug, Food, infectious, Manufacturing, Medical, Mologic Ltd, ODX, Omega Diagnostics, Omega Diagnostics Gp, Rapid Test, scientists, Screen4, UK Government, UK-RTC, University of Oxford
**Featured image:** ![](https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1)

---

**Peer-reviewed performance evaluation and self-test user experience of AbC 19TM**

**Omega (AIM: ODX),** the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued today by the UK Rapid Test Consortium (“UK-RTC”), of which Omega is a partner, welcoming the publication of two peer-reviewed studies conducted by Ulster University and involving AbC-19™, a lateral flow test for the detection of neutralising IgG antibodies to the full trimeric spike protein of the SARS-CoV-2 virus.

**Highlights from the studies include:**

· Excellent laboratory validation performance metrics for the AbC-19™ rapid test for SARS-CoV-2 spike protein IgG antibody detection and semi-quantitative correlation with laboratory ELISA methods assaying IgG antibodies to the spike protein of the SARS-CoV-2 virus.

· AbC-19™ showed sensitivity of 97.58% and specificity of 99.59% when using evaluation methods as defined by the MHRA for Target Product Profile of an antibody test.

· In addition, the study notes that IgG antibodies to the SARS-CoV-2 virus were detected 10 months after infection. Understanding the longevity of COVID-19 antibodies is important

both immunologically and in helping to guide pandemic exit protocols.

· Positive user experience score from 1,544 participants who used AbC-19™ as a ‘self-test’

**Professor Chris Molloy, Independent chairman of the UK Rapid Test Consortium said:** “We are entering a phase of the pandemic where testing for immunity will become as or more important than testing for infection. Rapid, accurate immunity tests are therefore a critical tool for citizens and public health providers to embrace.

“Development of multiple antibody tests, and semi-quantitative approaches will enhance this portfolio and enable the most rapid global recovery.”

**The UK-RTC press release can be read in full here:**

https://www.abc19.com/peer-reviewed-performance-evaluation-and-self-test-user-experience-of-abc-19/

 

---

**Original URL:** https://www.share-talk.com/omega-diagnostics-gp-odx-l-abc-19-rapid-antibody-test-performance-evaluation/
*Created by [WP Markdown Endpoint](https://wpmarkdownendpoint.com/)*